Our results subsequently revealed that circLIFR could sponge miR-624-5p, thereby upregulating GSK-3β expression, further facilitating the degradation of β-catenin and ultimately inactivating the GSK-3β/β-catenin signaling pathway in HCC cells. The gene discussed is GSK3B; the disease is hepatocellular carcinoma.